Forget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade
View original at finance.yahoo.comForget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade Quick Read DGRW outpaced SCHD 75% to 51% over five years and pays monthly dividends versus SCHD's quarterly schedule, making it more practical for retirees…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Over ten years SCHD returned 232% versus DGRW's 270%, an outperformance of 38 percentage points
60% confidenceThe analyst who called NVIDIA in 2010 has named his top 10 AI stocks and DGRW did not make the cut
60% confidenceOver the trailing five years SCHD returned 51% and DGRW returned 74.9% on a price-adjusted basis
60% confidenceSCHD charges a 0.06% expense ratio and holds roughly $95.1 billion in net assets
60% confidenceIn calendar year 2025, DGRW returned 12.51% while SCHD returned 4.56%
60% confidenceDGRW's 0.28% expense ratio is 4.5 times higher than SCHD's 0.06%
60% confidenceSCHD tracks the Dow Jones U.S. Dividend 100 Index, a rules-based screen emphasizing sustainable yield, cash flow to debt, return on equity, and consistent dividend growth
60% confidenceSCHD's top ten positions include Texas Instruments at 5.59%, UnitedHealth Group at 5.55%, Qualcomm at 5.53%, Coca-Cola at 4.08%, Chevron at 3.94%, and Merck at 3.90%
60% confidenceSCHD pays a higher headline yield than the broad market but earns that yield by underweighting sectors that have led U.S. equity returns for most of the last decade
60% confidenceDGRW pays monthly dividends versus SCHD's quarterly schedule, making it more practical for retirees
60% confidenceSCHD's value tilt drove a 25.78% trailing-year return compared to DGRW's 17.86%
60% confidenceDGRW outpaced SCHD 75% to 51% over the trailing five years on a price-adjusted total return basis
60% confidence
Data points we hold from this source
| Merck & Co., Inc. · market share | 3.90 percent |